QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 puma-biotechnology-raises-fy2025-sales-guidance-from-212000m-222000m-to-220000m-223000m-vs-216500m-est

Puma Biotechnology (NASDAQ:PBYI) raises FY2025 sales outlook from $212.000 million-$222.000 million to $220.000 million-$223.00...

 puma-biotechnology-sees-q4-sales-67000m-70000m-vs-66600m-est

Puma Biotechnology (NASDAQ:PBYI) sees Q4 sales of $67.000 million-$70.000 million vs $66.600 million analyst estimate.

 puma-biotechnology-q3-adj-eps-021-beats-004-estimate-sales-54500m-beat-51000m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0...

 puma-biotechnology-affirms-fy2025-sales-guidance-of-212000m-222000m-vs-217800m-est

Puma Biotechnology (NASDAQ:PBYI) affirms FY2025 sales outlook from $212.000 million-$222.000 million to $212.000 million-$222.0...

 puma-biotechnology-sees-q3-sales-48000m-51000m-vs-60000m-est

Puma Biotechnology (NASDAQ:PBYI) sees Q3 sales of $48.000 million-$51.000 million vs $60.000 million analyst estimate.

 puma-biotechnology-q2-adj-eps-015-beats-010-estimate-sales-4920m-miss-5075m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0...

 puma-biotechnology-q1-adj-eps-010-beats-002-estimate-sales-4600m-beat-4455m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 puma-biotechnology-sees-q1-sales-42500m-45500m-vs-4750m-est

Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $42.500 million-$45.500 million vs $47.50 million analyst estimate.

 puma-biotechnology-sees-fy2025-sales-212000m-222000m-vs-20790m-est

Puma Biotechnology (NASDAQ:PBYI) sees FY2025 sales of $212.000 million-$222.000 million vs $207.90 million analyst estimate.

 puma-biotechnology-q4-adj-eps-043-beats-010-estimate-sales-5910m-beat-5250m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION